Course of the study The BPC-157 peptide was administered to rats in drinking water or by injections, combined with the cuprizone toxin
pharmacies hold this designationare held to documented standards for potency testing, ingredient sourcing from FDA-registered suppliers, staff competency, and compliance with USP 795 (non-sterile) and 797 (sterile) compounding standards
The peptide does not affect blood pressure, heart rate, or cardiovascular parameters in studies
Last reviewed: May 31, 2026 Last updated: May 31, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Progression independent of relapse activity (PIRA) Progression independent of relapse activity indicating accumulation of irreversible clinical disability and CNS demyelination in the absence of overt inflammatory relapses
This makes it a candidate for oral or subcutaneous delivery depending on the goal
